Asian Phytoceuticals Public Company Limited

Financial Health of Asian Phytoceuticals Public Company Limited

Comparing to competitors in the Household & Personal Products industry

Industry Rankings

Richest
#166 / 198

Total Sales
#162 / 198

Making Money
#119 / 198

Working Efficiently
#3 / 198

Asian Phytoceuticals Public Company Limited
Buy, Hold or Sell?

Should you buy, hold or sell Asian Phytoceuticals Public Company Limited?

I guess you are interested in Asian Phytoceuticals Public Company Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Asian Phytoceuticals Public Company Limited

Let's start. I'm going to help you getting a better view of Asian Phytoceuticals Public Company Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Show more...

Company's Financial Health
A deep dive into the books. How are the numbers doing? Is Asian Phytoceuticals Public Company Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
Market Valuation
Finally, you now have an insight of how Asian Phytoceuticals Public Company Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Asian Phytoceuticals Public Company Limited. The closing price on 2022-12-01 was ฿4.7 per share. Is the company over- or underpriced?
Key Performance Indicators
A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.

Asian Phytoceuticals Public Company Limited Daily Candlestick Chart

Summary

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Asian Phytoceuticals Public Company Limited.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Asian Phytoceuticals Public Company Limited earns for each ฿1 of revenue.

Above 10% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
A Net Profit Margin of 33.3% means that ฿0.33 for each ฿1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 33.3%. The company is making a huge profit. +2
The TTM is 31.2%. The company is making a huge profit. +2

Trends

Current period		Compared to		+/-
MRQ	33.3%	TTM	31.2%	+2.1%
TTM	31.2%	YOY	28.0%	+3.2%
TTM	31.2%	5Y	27.7%	+3.5%
5Y	27.7%	10Y	26.7%	+1.0%

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	33.3%	3.8%	+29.5%
TTM	31.2%	3.3%	+27.9%
YOY	28.0%	5.2%	+22.8%
5Y	27.7%	4.1%	+23.6%
10Y	26.7%	4.7%	+22.0%

Measures how much net profit Asian Phytoceuticals Public Company Limited earns for each ฿1 of revenue.

Revenue is the amount of profit Asian Phytoceuticals Public Company Limited generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you ฿3. The company does not earn ฿3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is ฿1.5.

The ฿3 you pay for a cup of coffee is called revenue.
The ฿1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Asian Phytoceuticals Public Company Limited earns for each ฿1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
Can be used to compare companies within the Household & Personal Products industry.

You typically want a high profit margin. This means that for each ฿1 in sales, Asian Phytoceuticals Public Company Limited makes more profit. This shows the investor how efficiently Asian Phytoceuticals Public Company Limited is operating in general and compared to other companies in the same industry. Asian Phytoceuticals Public Company Limited operates in the Household & Personal Products industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Asian Phytoceuticals Public Company Limited. If profit margins remain low (compared to the Household & Personal Products industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Asian Phytoceuticals Public Company Limited is 0.33. This means that Asian Phytoceuticals Public Company Limited earned ฿0.33 for each ฿1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Household & Personal Products industry is 3.8%.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Asian Phytoceuticals Public Company Limited with other companies in the same industry (Household & Personal Products).
Net profit margin should rise over the years.
Can be influenced when Asian Phytoceuticals Public Company Limited sells assets (profit will increase while costs remain the same).
It won’t show what part of Asian Phytoceuticals Public Company Limited is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Asian Phytoceuticals Public Company Limited

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Asian Phytoceuticals Public Company Limited = 20,924
Total revenue MRQ Asian Phytoceuticals Public Company Limited = 62,781
฿20,924 / ฿62,781 = 0.33 or 33.3%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Asian Phytoceuticals Public Company Limited is using its assets to generate profit.

Above 5% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
3.3% Return on Assets means that Asian Phytoceuticals Public Company Limited generated ฿0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 3.3%. Using its assets, the company is less efficient in making profit.
The TTM is 2.8%. Using its assets, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	3.3%	TTM	2.8%	+0.4%
TTM	2.8%	YOY	2.4%	+0.4%
TTM	2.8%	5Y	2.9%	0.0%
5Y	2.9%	10Y	3.8%	-0.9%

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	3.3%	0.9%	+2.4%
TTM	2.8%	0.9%	+1.9%
YOY	2.4%	1.3%	+1.1%
5Y	2.9%	1.1%	+1.8%
10Y	3.8%	1.3%	+2.5%

Shows how efficient Asian Phytoceuticals Public Company Limited is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Asian Phytoceuticals Public Company Limited is using its resources to generate profit. If the return on assets (3.3%) from Asian Phytoceuticals Public Company Limited are higher than the Household & Personal Products mean (0.9%) that means Asian Phytoceuticals Public Company Limited is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Asian Phytoceuticals Public Company Limited is 3.3%. This means the company generated ฿0.03 for each ฿1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Household & Personal Products industry is 0.9%.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Asian Phytoceuticals Public Company Limited

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Asian Phytoceuticals Public Company Limited = 20,924
Total assets MRQ (balance sheet) from Asian Phytoceuticals Public Company Limited = 641,478
20,924 / 641,478 = 0.03 or 3.3%

ROA is an important ratio as it will tell you how effectively Asian Phytoceuticals Public Company Limited is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Asian Phytoceuticals Public Company Limited is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
3.6% Return on Equity means Asian Phytoceuticals Public Company Limited generated ฿0.04 for each ฿1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 3.6%. Using its investors money, the company is inefficient in making profit. -1
The TTM is 3.2%. Using its investors money, the company is inefficient in making profit. -1

Trends

Current period		Compared to		+/-
MRQ	3.6%	TTM	3.2%	+0.4%
TTM	3.2%	YOY	2.8%	+0.4%
TTM	3.2%	5Y	3.2%	+0.0%
5Y	3.2%	10Y	4.3%	-1.1%

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	3.6%	2.1%	+1.5%
TTM	3.2%	1.9%	+1.3%
YOY	2.8%	3.0%	-0.2%
5Y	3.2%	2.2%	+1.0%
10Y	4.3%	2.5%	+1.8%

Shows how efficient Asian Phytoceuticals Public Company Limited is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Household & Personal Products industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Asian Phytoceuticals Public Company Limited is 3.6%. This means Asian Phytoceuticals Public Company Limited generated ฿0.04 for each ฿1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Household & Personal Products industry is 2.1%.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if Asian Phytoceuticals Public Company Limited existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Asian Phytoceuticals Public Company Limited

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Asian Phytoceuticals Public Company Limited = 20,924
Shareholders equity (balance sheet) MRQ Asian Phytoceuticals Public Company Limited = 574,390
20,924 / 574,390 = 0.04 or 3.6%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Asian Phytoceuticals Public Company Limited.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Asian Phytoceuticals Public Company Limited is operating .

Measures how much profit Asian Phytoceuticals Public Company Limited makes for each ฿1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
An Operating Margin of 36.7% means the company generated ฿0.37 for each ฿1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 36.7%. The company is operating very efficient. +2
The TTM is 34.6%. The company is operating very efficient. +2

Trends

Current period		Compared to		+/-
MRQ	36.7%	TTM	34.6%	+2.1%
TTM	34.6%	YOY	29.0%	+5.7%
TTM	34.6%	5Y	32.1%	+2.5%
5Y	32.1%	10Y	18.9%	+13.2%

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	36.7%	4.5%	+32.2%
TTM	34.6%	3.5%	+31.1%
YOY	29.0%	6.1%	+22.9%
5Y	32.1%	5.9%	+26.2%
10Y	18.9%	6.0%	+12.9%

Measures how efficient Asian Phytoceuticals Public Company Limited is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Asian Phytoceuticals Public Company Limited is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Asian Phytoceuticals Public Company Limited is 36.7%. This means that Asian Phytoceuticals Public Company Limited earned ฿0.37 for each ฿1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Household & Personal Products industry is 4.5%.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Asian Phytoceuticals Public Company Limited

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Asian Phytoceuticals Public Company Limited = 23,038
Total revenue MRQ Asian Phytoceuticals Public Company Limited = 62,781
฿23,038 / ฿62,781 = 0.37 or 36.7%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Asian Phytoceuticals Public Company Limited is keeping operating costs low.

Below 1 is considered healthy (always compare to Household & Personal Products industry mean).
An Operation Ratio of 0.82 means that the operating costs are ฿0.82 for each ฿1 in net sales.

Let's take a look of the Operating Ratio trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 0.823. The company is less efficient in keeping operating costs low.
The TTM is 0.848. The company is less efficient in keeping operating costs low.

Trends

Current period		Compared to		+/-
MRQ	0.823	TTM	0.848	-0.025
TTM	0.848	YOY	0.925	-0.076
TTM	0.848	5Y	0.891	-0.043
5Y	0.891	10Y	0.581	+0.310

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	0.823	1.314	-0.491
TTM	0.848	1.207	-0.359
YOY	0.925	1.046	-0.121
5Y	0.891	0.986	-0.095
10Y	0.581	0.935	-0.354

Measures how efficient Asian Phytoceuticals Public Company Limited is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Asian Phytoceuticals Public Company Limited is 82.3%. This means that Asian Phytoceuticals Public Company Limited earned ฿0.82 for each ฿1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Household & Personal Products industry is 1.31.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Asian Phytoceuticals Public Company Limited

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(11,927 +39,744) \ 62,781 = 0.82

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Asian Phytoceuticals Public Company Limited.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Asian Phytoceuticals Public Company Limited is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Household & Personal Products industry mean).
A Current Ratio of 6.23 means the company has ฿6.23 in assets for each ฿1 in short-term debts.

Let's take a look of the Current Ratio trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 6.227. The company is very able to pay all its short-term debts. +2
The TTM is 5.431. The company is very able to pay all its short-term debts. +2

Trends

Current period		Compared to		+/-
MRQ	6.227	TTM	5.431	+0.797
TTM	5.431	YOY	5.222	+0.209
TTM	5.431	5Y	10.710	-5.280
5Y	10.710	10Y	6.700	+4.010

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	6.227	1.634	+4.593
TTM	5.431	1.569	+3.862
YOY	5.222	1.643	+3.579
5Y	10.710	1.661	+9.049
10Y	6.700	1.442	+5.258

Measures if Asian Phytoceuticals Public Company Limited is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Household & Personal Products industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Asian Phytoceuticals Public Company Limited if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Asian Phytoceuticals Public Company Limited is 6.23. This means Asian Phytoceuticals Public Company Limited has ฿6.23 in assets for each ฿1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Household & Personal Products industry is 1.63.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Asian Phytoceuticals Public Company Limited

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
249,555 \ 40,075) = 6.23

The current ratio measures if Asian Phytoceuticals Public Company Limited is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Asian Phytoceuticals Public Company Limited is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Asian Phytoceuticals Public Company Limited does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Asian Phytoceuticals Public Company Limited is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Asian Phytoceuticals Public Company Limited is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
A Quick Ratio of 3.18 means the company can pay off ฿3.18 for each ฿1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 3.183. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 2.231. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	3.183	TTM	2.231	+0.951
TTM	2.231	YOY	1.963	+0.268
TTM	2.231	5Y	5.221	-2.989
5Y	5.221	10Y	3.429	+1.792

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	3.183	0.658	+2.525
TTM	2.231	0.655	+1.576
YOY	1.963	0.732	+1.231
5Y	5.221	0.721	+4.500
10Y	3.429	0.674	+2.755

Measures if Asian Phytoceuticals Public Company Limited is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast Asian Phytoceuticals Public Company Limited can pay off its short term debts. This shows if Asian Phytoceuticals Public Company Limited can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of Asian Phytoceuticals Public Company Limited is 3.18. This means that Asian Phytoceuticals Public Company Limited can pay off ฿3.18 for each ฿1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Household & Personal Products industry is 0.66.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example Asian Phytoceuticals Public Company Limited

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio Asian Phytoceuticals Public Company Limited: ( + 123,809 +3,729) / 40,075 = 3.18

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of Asian Phytoceuticals Public Company Limited.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Asian Phytoceuticals Public Company Limited assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Asian Phytoceuticals Public Company Limited to Household & Personal Products industry mean.
A Debt to Asset Ratio of 0.10 means that Asian Phytoceuticals Public Company Limited assets are financed with 10.1% credit (debt) and the remaining percentage (100% - 10.1%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 0.101. The company is very able to pay all its debts by selling its assets. +2
The TTM is 0.114. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.101	TTM	0.114	-0.013
TTM	0.114	YOY	0.136	-0.023
TTM	0.114	5Y	0.099	+0.014
5Y	0.099	10Y	0.104	-0.005

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	0.101	0.453	-0.352
TTM	0.114	0.441	-0.327
YOY	0.136	0.431	-0.295
5Y	0.099	0.425	-0.326
10Y	0.104	0.421	-0.317

Measures how much % of Asian Phytoceuticals Public Company Limited assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Asian Phytoceuticals Public Company Limited than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Asian Phytoceuticals Public Company Limited to Household & Personal Products industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Asian Phytoceuticals Public Company Limited is 0.10. This means means that Asian Phytoceuticals Public Company Limited is financed with 10.1% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Household & Personal Products industry is 163.4%.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Asian Phytoceuticals Public Company Limited has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Asian Phytoceuticals Public Company Limited

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
64,697 \ 641,478 = 10.1% or 0.10.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Asian Phytoceuticals Public Company Limited is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
A Debt to Equity ratio of 11.3% means that company has ฿0.11 debt for each ฿1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 0.113. The company is very able to pay all its debts with equity. +2
The TTM is 0.129. The company is very able to pay all its debts with equity. +2

Trends

Current period		Compared to		+/-
MRQ	0.113	TTM	0.129	-0.016
TTM	0.129	YOY	0.158	-0.029
TTM	0.129	5Y	0.111	+0.017
5Y	0.111	10Y	0.120	-0.009

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	0.113	0.819	-0.706
TTM	0.129	0.782	-0.653
YOY	0.158	0.720	-0.562
5Y	0.111	0.747	-0.636
10Y	0.120	0.759	-0.639

Measures if Asian Phytoceuticals Public Company Limited is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Asian Phytoceuticals Public Company Limited is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Asian Phytoceuticals Public Company Limited is 0.11. This means that Asian Phytoceuticals Public Company Limited can pay off ฿0.11 for each ฿1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Household & Personal Products industry is 0.82.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Asian Phytoceuticals Public Company Limited

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
64,697 \ 574,390 = 0.11 or 11.3%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Asian Phytoceuticals Public Company Limited

2. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ฿1 in earnings Asian Phytoceuticals Public Company Limited generates.

Above 15 is considered overpriced but always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
A PE ratio of 137.06 means the investor is paying ฿137.06 for every ฿1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Asian Phytoceuticals Public Company Limited:

The EOD is 134.771. Seems overpriced? -1
The MRQ is 137.065. Seems overpriced? -1
The TTM is 172.554. Seems overpriced? -1

Trends

Current period		Compared to		+/-
EOD	134.771	MRQ	137.065	-2.294
MRQ	137.065	TTM	172.554	-35.489
TTM	172.554	YOY	179.050	-6.496
TTM	172.554	5Y	149.042	+23.512
5Y	149.042	10Y	162.831	-13.789

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
EOD	134.771	51.692	+83.079
MRQ	137.065	55.784	+81.281
TTM	172.554	56.960	+115.594
YOY	179.050	73.878	+105.172
5Y	149.042	51.010	+98.032
10Y	162.831	42.705	+120.126

Measures how much money you pay for each share for every ฿1 in earnings Asian Phytoceuticals Public Company Limited generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Asian Phytoceuticals Public Company Limited to the Household & Personal Products industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Asian Phytoceuticals Public Company Limited is 137.06. This means the investor is paying ฿137.06 for every ฿1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Household & Personal Products industry is 55.78.
What is the trend?
The trend is important because it shows you how Asian Phytoceuticals Public Company Limited is performing over time. The most recent quarter might be important if Asian Phytoceuticals Public Company Limited released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Asian Phytoceuticals Public Company Limited up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Asian Phytoceuticals Public Company Limited

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
20,924 \ 600,000 = EPS
PE ratio MRQ = 137.06

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Asian Phytoceuticals Public Company Limited.

Lower is better.
A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Asian Phytoceuticals Public Company Limited:

The MRQ is 766.188. Seems overpriced? -1
The TTM is 832.982. Seems overpriced? -1

Trends

Current period		Compared to		+/-
MRQ	766.188	TTM	832.982	-66.795
TTM	832.982	YOY	-35,181.855	+36,014.837
TTM	832.982	5Y	-11,204.816	+12,037.798
5Y	-11,204.816	10Y	-5,397.036	-5,807.780

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
MRQ	766.188	0.205	+765.983
TTM	832.982	-0.078	+833.060
YOY	-35,181.855	-0.049	-35,181.806
5Y	-11,204.816	-0.183	-11,204.633
10Y	-5,397.036	-0.202	-5,396.834

PEG Ratio	Meaning
0.5	You can buy the stock cheap based on future growth
1	You pay a fair price based on future growth
2	The stock is overpriced based on future growth

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Asian Phytoceuticals Public Company Limited is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Household & Personal Products industry mean).
A PB ratio of 4.97 means the investor is paying ฿4.97 for each ฿1 in book value.

Let's take a look of the Price to Book Ratio trends of Asian Phytoceuticals Public Company Limited:

The EOD is 4.889. Neutral. Compare to industry.
The MRQ is 4.972. Neutral. Compare to industry.
The TTM is 5.445. Seems overpriced? -1

Trends

Current period		Compared to		+/-
EOD	4.889	MRQ	4.972	-0.083
MRQ	4.972	TTM	5.445	-0.473
TTM	5.445	YOY	4.601	+0.844
TTM	5.445	5Y	4.535	+0.910
5Y	4.535	10Y	6.675	-2.141

Compared to industry (Household & Personal Products)

Period	Company	Industry (mean)	+/-
EOD	4.889	1.544	+3.345
MRQ	4.972	1.792	+3.180
TTM	5.445	1.997	+3.448
YOY	4.601	2.211	+2.390
5Y	4.535	1.942	+2.593
10Y	6.675	1.861	+4.814

2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Asian Phytoceuticals Public Company Limited compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	0.034	0.001	+3175%	0.002	+1873%	-0.002	+105%	0.009	+273%
Book Value Growth	-	-	0.972	0.971	+0%	0.971	+0%	0.971	+0%	0.971	+0%
Book Value Per Share	-	-	0.961	0.976	-2%	0.972	-1%	0.981	-2%	0.904	+6%
Book Value Per Share Growth	-	-	0.035	-0.001	+102%	0.000	+7572%	-0.004	+111%	0.007	+375%
Current Ratio	-	-	6.227	5.431	+15%	5.222	+19%	10.710	-42%	6.700	-7%
Debt To Asset Ratio	-	-	0.101	0.114	-11%	0.136	-26%	0.099	+1%	0.104	-3%
Debt To Equity Ratio	-	-	0.113	0.129	-12%	0.158	-29%	0.111	+1%	0.120	-6%
Dividend Per Share	-	-	-	0.092	-100%	0.121	-100%	0.118	-100%	0.115	-100%
Eps	-	-	0.035	0.031	+12%	0.027	+30%	0.031	+11%	0.038	-7%
Eps Growth	-	-	0.179	0.000	+56633%	-0.075	+142%	-0.066	+137%	-0.047	+126%
Gross Profit Margin	-	-	1.000	1.000	0%	1.000	0%	1.000	0%	1.000	0%
Net Profit Margin	-	-	0.333	0.312	+7%	0.280	+19%	0.277	+20%	0.267	+25%
Operating Margin	-	-	0.367	0.346	+6%	0.290	+27%	0.321	+14%	0.189	+94%
Operating Ratio	-	-	0.823	0.848	-3%	0.925	-11%	0.891	-8%	0.581	+42%
Pb Ratio	4.889	-2%	4.972	5.445	-9%	4.601	+8%	4.535	+10%	6.675	-26%
Pe Ratio	134.771	-2%	137.065	172.554	-21%	179.050	-23%	149.042	-8%	162.831	-16%
Peg Ratio	-	-	766.188	832.982	-8%	-35181.855	+4692%	-11204.816	+1562%	-5397.036	+804%
Price Per Share	4.700	-2%	4.780	5.318	-10%	4.460	+7%	4.456	+7%	5.900	-19%
Price To Total Gains Ratio	139.176	-2%	141.545	99.664	+42%	51.135	+177%	73.393	+93%	65.851	+115%
Profit Growth	-	-	97.658	97.120	+1%	96.903	+1%	96.928	+1%	96.984	+1%
Quick Ratio	-	-	3.183	2.231	+43%	1.963	+62%	5.221	-39%	3.429	-7%
Return On Assets	-	-	0.033	0.028	+15%	0.024	+36%	0.029	+13%	0.038	-14%
Return On Equity	-	-	0.036	0.032	+14%	0.028	+31%	0.032	+14%	0.043	-15%
Revenue Growth	-	-	0.973	0.972	+0%	0.970	+0%	0.970	+0%	0.971	+0%
Total Gains Per Share	-	-	0.034	0.094	-64%	0.122	-72%	0.116	-71%	0.124	-73%
Total Gains Per Share Growth	-	-	0.203	-1.139	+662%	-0.500	+347%	-1.049	+618%	-0.909	+548%
Usd Book Value	-	-	16611303.974	16867065.744	-2%	16799487.214	-1%	16953165.151	-2%	15628505.656	+6%
Usd Book Value Change Per Share	-	-	0.001	0.000	+3175%	0.000	+1873%	0.000	+105%	0.000	+273%
Usd Book Value Per Share	-	-	0.028	0.028	-2%	0.028	-1%	0.028	-2%	0.026	+6%
Usd Dividend Per Share	-	-	-	0.003	-100%	0.003	-100%	0.003	-100%	0.003	-100%
Usd Eps	-	-	0.001	0.001	+12%	0.001	+30%	0.001	+11%	0.001	-7%
Usd Price Per Share	0.135	-2%	0.138	0.153	-10%	0.128	+7%	0.128	+7%	0.170	-19%
Usd Profit	-	-	602623.843	538467.962	+12%	463289.630	+30%	541572.993	+11%	648269.946	-7%
Usd Revenue	-	-	1808102.045	1715616.734	+5%	1639388.448	+10%	1977627.012	-9%	2429060.106	-26%
Usd Total Gains Per Share	-	-	0.001	0.003	-64%	0.004	-72%	0.003	-71%	0.004	-73%
	EOD	+3 -2	MRQ	TTM	+26 -8	YOY	+24 -10	5Y	+19 -15	10Y	+19 -15

3.2. Fundamental Score

Let's check the fundamental score of Asian Phytoceuticals Public Company Limited based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	134.771
Price to Book Ratio (EOD)	Between	0-1	4.889
Net Profit Margin (MRQ)	Greater than	0	0.333
Operating Margin (MRQ)	Greater than	0	0.367
Quick Ratio (MRQ)	Greater than	1	3.183
Current Ratio (MRQ)	Greater than	1	6.227
Debt to Asset Ratio (MRQ)	Less than	1	0.101
Debt to Equity Ratio (MRQ)	Less than	1	0.113
Return on Equity (MRQ)	Greater than	0.15	0.036
Return on Assets (MRQ)	Greater than	0.05	0.033
Total			6/10 (60.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

3.3. Technical Score

Let's check the technical score of Asian Phytoceuticals Public Company Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Open	Greater than	Close	4.660
Total			0/1 (0.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in THB. All numbers in thousands.

Summary

Total Assets	641,478
Total Liabilities	64,697
Total Stockholder Equity	574,390

	As reported
Total Liabilities	64,697
Total Stockholder Equity	+ 574,390
Total Assets	= 641,478

Assets

Total Assets	641,478
Total Current Assets	249,555
Long-term Assets	249,555

Total Current Assets

Total Current Assets (as reported)	249,555
Cash And Cash Equivalents	63,721
Short-term Investments	123,809
Net Receivables	3,729
Inventory	56,851
Other Current Assets	355
Total Current Assets (calculated)	248,465
+/-	1,089

Long-term Assets

Long-term Assets (as reported)	391,923
Property Plant Equipment	69,554
Long Term Investments	308,905
Other Assets	13,199
Long-term Assets (calculated)	391,658
+/-	266

Liabilities & Shareholders' Equity

Total Current Liabilities	40,075
Long-term Liabilities	24,622
Total Stockholder Equity	574,390

Total Current Liabilities

Total Current Liabilities (as reported)	40,075
Accounts payable	1,929
Other Current Liabilities	9,190
Total Current Liabilities (calculated)	11,119
+/-	28,955

Long-term Liabilities

Long-term Liabilities (as reported)	24,622
Other Liabilities	22,497
Long-term Liabilities (calculated)	22,497
+/-	2,125

Total Stockholder Equity

Total Stockholder Equity (as reported)	574,390
Common Stock	300,000
Retained Earnings	118,810
Total Stockholder Equity (calculated)	418,810
+/-	155,580

Other

Capital Stock	300,000
Common Stock Shares Outstanding	600,000
Net Invested Capital	574,390
Net Tangible Assets	574,124
Net Working Capital	209,480

Balance Sheet

Currency in THB. All numbers in thousands.

Trend

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-03-31

2009-12-31

2008-12-31

2007-12-31

> Total Assets

137,564
171,749
230,367
0
217,529
237,851
198,503
261,013
410,217
424,119
377,178
393,458
423,539
433,077
399,019
417,484
457,159
486,042
513,956
538,153
562,605
596,053
557,706
576,166
628,976
653,602
580,929
607,845
711,185
736,417
613,887
642,814
678,780
712,071
611,350
636,300
665,721
684,907
597,050
608,053
629,758
666,709
620,583
623,626
696,778
702,894
647,225
654,413
680,533
694,638
626,889
641,478

641,478

626,889

694,638

680,533

654,413

647,225

702,894

696,778

623,626

620,583

666,709

629,758

608,053

597,050

684,907

665,721

636,300

611,350

712,071

678,780

642,814

613,887

736,417

711,185

607,845

580,929

653,602

628,976

576,166

557,706

596,053

562,605

538,153

513,956

486,042

457,159

417,484

399,019

433,077

423,539

393,458

377,178

424,119

410,217

261,013

198,503

237,851

217,529

230,367

171,749

137,564

> Total Current Assets

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
595,591
621,894
502,930
534,848
573,627
609,830
510,555
538,283
569,416
590,475
504,910
519,191
544,522
571,136
322,664
277,482
240,717
268,650
217,091
205,677
231,112
273,021
212,802
249,555

249,555

212,802

273,021

231,112

205,677

217,091

268,650

240,717

277,482

322,664

571,136

544,522

519,191

504,910

590,475

569,416

538,283

510,555

609,830

573,627

534,848

502,930

621,894

595,591

Cash And Cash Equivalents

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222,498
248,549
166,192
195,401
244,302
278,141
172,659
185,791
182,356
204,862
114,239
130,984
160,282
505,718
75,672
81,875
100,201
110,911
49,432
63,958
98,593
118,185
54,986
63,721

63,721

54,986

118,185

98,593

63,958

49,432

110,911

100,201

81,875

75,672

505,718

160,282

130,984

114,239

204,862

182,356

185,791

172,659

278,141

244,302

195,401

166,192

248,549

222,498

Short-term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
315,496
315,496
270,601
270,601
270,520
270,525
271,002
271,090
313,394
313,399
315,972
316,514
319,512
534
157,480
125,429
71,835
90,513
97,048
73,971
68,323
91,558
87,060
123,809

123,809

87,060

91,558

68,323

73,971

97,048

90,513

71,835

125,429

157,480

534

319,512

316,514

315,972

313,399

313,394

271,090

271,002

270,525

270,520

270,601

315,496

Net Receivables

6,674
14,098
18,952
0
19,342
19,359
7,704
7,834
11,693
9,821
8,683
6,964
7,193
2,914
10,433
13,765
10,591
8,549
12,333
18,756
13,710
23,066
19,681
11,277
10,081
6,307
6,153
5,454
4,967
6,085
7,176
8,979
4,551
7,289
5,939
5,616
5,248
2,800
3,487
1,893
1,443
1,757
18,754
2,244
5,294
2,490
3,980
3,606
3,286
2,603
10,344
3,729

3,729

10,344

2,603

3,286

3,606

3,980

2,490

5,294

2,244

18,754

1,757

1,443

1,893

3,487

2,800

5,248

5,616

5,939

7,289

4,551

8,979

7,176

6,085

4,967

5,454

6,153

6,307

10,081

11,277

19,681

23,066

13,710

18,756

12,333

8,549

10,591

13,765

10,433

2,914

7,193

6,964

8,683

9,821

11,693

7,834

7,704

19,359

19,342

18,952

14,098

6,674

Other Current Assets

1,413
1,215
1,763
0
1,860
2,619
2,965
3,560
2,366
2,272
3,272
3,476
3,408
4,158
3,948
4,358
4,903
5,408
7,592
4,761
3,677
5,444
4,939
7,355
5,786
6,031
6,033
5,866
4,456
5,784
4,895
4,361
3,200
4,291
2,758
2,980
623
640
554
382
347
359
379
397
348
357
335
337
302
444
318
355

355

318

444

302

337

335

357

348

397

379

359

347

382

554

640

623

2,980

2,758

4,291

3,200

4,361

4,895

5,784

4,456

5,866

6,033

6,031

5,786

7,355

4,939

5,444

3,677

4,761

7,592

5,408

4,903

4,358

3,948

4,158

3,408

3,476

3,272

2,272

2,366

3,560

2,965

2,619

1,860

1,763

1,215

1,413

> Long-term Assets

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,432
92,140
88,862
85,236
95,572
297,919
346,144
456,061
434,244
430,134
448,736
449,420
421,617
414,087
391,923

391,923

414,087

421,617

449,420

448,736

430,134

434,244

456,061

346,144

297,919

95,572

85,236

88,862

92,140

94,432

Property Plant Equipment

54,932
60,378
60,196
0
60,129
58,982
71,206
72,282
71,075
82,248
81,840
82,112
88,079
87,675
86,015
84,661
91,509
88,043
90,371
93,607
105,743
146,654
151,537
150,415
146,682
142,697
138,570
134,896
106,712
104,019
100,562
97,190
93,772
90,546
88,517
85,274
83,607
81,176
78,014
74,654
71,355
80,517
73,157
67,940
113,390
105,907
101,628
95,535
91,208
80,495
75,109
69,554

69,554

75,109

80,495

91,208

95,535

101,628

105,907

113,390

67,940

73,157

80,517

71,355

74,654

78,014

81,176

83,607

85,274

88,517

90,546

93,772

97,190

100,562

104,019

106,712

134,896

138,570

142,697

146,682

150,415

151,537

146,654

105,743

93,607

90,371

88,043

91,509

84,661

86,015

87,675

88,079

82,112

81,840

82,248

71,075

72,282

71,206

58,982

60,129

60,196

60,378

54,932

Long Term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,533
1,392
1,398
1,925
2,244
2,450
2,794
2,819
3,197
3,345
3,453
3,609
3,701
214,385
265,521
331,928
317,986
317,221
341,409
346,733
330,416
327,305
308,905

308,905

327,305

330,416

346,733

341,409

317,221

317,986

331,928

265,521

214,385

3,701

3,609

3,453

3,345

3,197

2,819

2,794

2,450

2,244

1,925

1,398

1,392

1,533

Intangible Assets

0
0
469
0
409
437
431
503
523
632
601
570
575
552
520
488
479
454
429
404
1,343
1,384
1,335
1,284
1,234
1,185
1,137
1,097
1,129
1,090
1,051
1,011
972
933
894
854
815
776
737
698
658
0
0
0
503
0
0
0
356
0
0
0

356

503

658

698

737

776

815

854

894

933

972

1,011

1,051

1,090

1,129

1,097

1,137

1,185

1,234

1,284

1,335

1,384

1,343

404

429

454

479

488

520

552

575

570

601

632

523

503

431

437

409

469

Long-term Assets Other

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,105
6,098
6,099
5,581
6,309
6,309
6,105
6,076
6,076
6,297
6,297
6,070
4,756
4,756
4,753

4,753

4,756

6,070

6,297

6,076

6,105

6,309

5,581

6,099

6,098

6,105

> Total Liabilities

15,837
29,947
52,756
0
31,602
45,923
44,053
36,100
38,604
40,094
32,257
34,048
46,195
42,162
41,049
38,055
52,883
133,285
50,598
40,479
47,561
174,435
47,835
44,964
60,797
60,554
54,318
48,299
62,084
63,189
48,628
46,017
50,468
58,611
47,193
47,054
51,558
55,401
48,802
44,935
50,567
70,331
59,438
53,426
101,314
96,247
90,379
80,107
85,538
80,285
70,370
64,697

64,697

70,370

80,285

85,538

80,107

90,379

96,247

101,314

53,426

59,438

70,331

50,567

44,935

48,802

55,401

51,558

47,054

47,193

58,611

50,468

46,017

48,628

63,189

62,084

48,299

54,318

60,554

60,797

44,964

47,835

174,435

47,561

40,479

50,598

133,285

52,883

38,055

41,049

42,162

46,195

34,048

32,257

40,094

38,604

36,100

44,053

45,923

31,602

52,756

29,947

15,837

> Total Current Liabilities

15,756
29,940
52,603
0
29,403
39,705
37,907
30,030
32,614
34,181
26,421
28,296
40,531
36,580
35,554
32,411
46,430
126,603
43,687
33,339
40,192
163,424
36,577
33,459
49,045
48,536
42,034
35,749
50,267
51,115
36,297
33,604
37,799
45,674
34,190
33,784
36,919
40,453
30,208
25,952
31,196
50,173
39,294
32,983
48,874
47,050
44,412
38,352
47,751
48,625
42,218
40,075

40,075

42,218

48,625

47,751

38,352

44,412

47,050

48,874

32,983

39,294

50,173

31,196

25,952

30,208

40,453

36,919

33,784

34,190

45,674

37,799

33,604

36,297

51,115

50,267

35,749

42,034

48,536

49,045

33,459

36,577

163,424

40,192

33,339

43,687

126,603

46,430

32,411

35,554

36,580

40,531

28,296

26,421

34,181

32,614

30,030

37,907

39,705

29,403

52,603

29,940

15,756

Accounts payable

788
869
3,062
0
2,117
3,806
1,722
1,705
1,638
2,183
1,853
2,555
1,177
2,437
2,546
2,451
1,963
3,603
2,499
3,796
1,387
2,096
1,418
2,193
1,863
1,017
1,721
1,948
1,745
2,648
2,118
1,921
1,548
2,289
1,229
4,530
1,735
629
1,818
785
690
3,196
3,062
1,686
631
648
1,432
853
1,992
1,311
1,392
1,929

1,929

1,392

1,311

1,992

853

1,432

648

631

1,686

3,062

3,196

690

785

1,818

629

1,735

4,530

1,229

2,289

1,548

1,921

2,118

2,648

1,745

1,948

1,721

1,017

1,863

2,193

1,418

2,096

1,387

3,796

2,499

3,603

1,963

2,451

2,546

2,437

1,177

2,555

1,853

2,183

1,638

1,705

1,722

3,806

2,117

3,062

869

788

Other Current Liabilities

4,883
20,899
41,390
0
26,395
34,996
35,298
27,453
30,119
31,154
23,719
24,873
38,469
33,241
32,088
28,580
43,999
123,000
41,188
29,543
38,806
161,329
35,159
31,266
47,183
47,519
40,312
33,801
48,522
48,466
34,178
31,684
36,251
43,385
14,082
9,324
16,047
2,110
1,913
1,880
11,155
16,300
12,256
8,986
12,950
15,535
11,806
7,127
13,233
18,416
13,709
9,190

9,190

13,709

18,416

13,233

7,127

11,806

15,535

12,950

8,986

12,256

16,300

11,155

1,880

1,913

2,110

16,047

9,324

14,082

43,385

36,251

31,684

34,178

48,466

48,522

33,801

40,312

47,519

47,183

31,266

35,159

161,329

38,806

29,543

41,188

123,000

43,999

28,580

32,088

33,241

38,469

24,873

23,719

31,154

30,119

27,453

35,298

34,996

26,395

41,390

20,899

4,883

> Long-term Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,948
18,595
18,983
19,371
20,158
20,144
20,443
52,440
49,197
45,967
41,755
37,787
31,660
28,152
24,622

24,622

28,152

31,660

37,787

41,755

45,967

49,197

52,440

20,443

20,144

20,158

19,371

18,983

18,595

14,948

Other Liabilities

0
0
0
0
0
4,246
4,377
4,507
4,637
4,775
4,916
5,056
5,195
5,345
5,495
5,645
6,453
6,682
6,911
7,140
7,369
11,011
11,258
11,505
11,752
12,018
12,284
12,550
11,817
12,074
12,331
12,413
12,670
12,937
13,003
13,270
14,639
14,948
18,595
18,983
19,371
19,645
20,049
20,443
20,848
21,262
20,921
21,335
22,301
21,717
22,107
22,497

22,497

22,107

21,717

22,301

21,335

20,921

21,262

20,848

20,443

20,049

19,645

19,371

18,983

18,595

14,948

14,639

13,270

13,003

12,937

12,670

12,413

12,331

12,074

11,817

12,550

12,284

12,018

11,752

11,505

11,258

11,011

7,369

7,140

6,911

6,682

6,453

5,645

5,495

5,345

5,195

5,056

4,916

4,775

4,637

4,507

4,377

4,246

> Total Stockholder Equity

121,726
141,802
177,611
177,611
185,927
191,928
154,450
224,912
371,613
384,025
344,921
359,409
377,343
390,914
357,969
379,428
404,276
352,757
463,359
497,675
515,044
421,617
509,871
531,202
568,179
593,048
526,612
559,546
649,101
673,229
565,259
596,797
628,311
653,460
564,157
589,246
614,163
629,506
548,248
563,118
579,191
596,377
561,144
570,199
595,464
606,647
556,845
574,306
594,995
614,105
554,440
574,390

574,390

554,440

614,105

594,995

574,306

556,845

606,647

595,464

570,199

561,144

596,377

579,191

563,118

548,248

629,506

614,163

589,246

564,157

653,460

628,311

596,797

565,259

673,229

649,101

559,546

526,612

593,048

568,179

531,202

509,871

421,617

515,044

497,675

463,359

352,757

404,276

379,428

357,969

390,914

377,343

359,409

344,921

384,025

371,613

224,912

154,450

191,928

185,927

177,611

141,802

121,726

Common Stock

93,000
93,000
93,000
0
93,000
93,000
93,000
150,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
272,000
272,000
272,000
272,000
274,538
274,538
274,538
274,538
274,538
274,538
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000

300,000

274,538

272,000

200,000

150,000

93,000

Retained Earnings

8,021
28,097
63,906
0
92,927
98,928
61,450
74,912
88,751
101,162
62,058
76,547
94,480
108,051
75,106
96,565
121,413
69,894
108,496
142,812
160,181
66,755
86,896
108,227
145,204
170,073
103,636
136,570
182,157
206,284
98,314
129,853
161,367
186,516
97,213
122,301
147,219
109,895
28,636
43,506
112,246
129,433
91,721
108,081
125,260
134,492
87,113
106,068
126,751
148,515
92,300
118,810

118,810

92,300

148,515

126,751

106,068

87,113

134,492

125,260

108,081

91,721

129,433

112,246

43,506

28,636

109,895

147,219

122,301

97,213

186,516

161,367

129,853

98,314

206,284

182,157

136,570

103,636

170,073

145,204

108,227

86,896

66,755

160,181

142,812

108,496

69,894

121,413

96,565

75,106

108,051

94,480

76,547

62,058

101,162

88,751

74,912

61,450

98,928

92,927

63,906

28,097

8,021

Capital Surplus

Treasury Stock

Other Stockholders Equity

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,479
-4,826
3,258
5,210
2,788
1,294
1,299
-1,354
-4,804
-11,365

-11,365

-4,804

-1,354

1,299

1,294

2,788

5,210

3,258

-4,826

2,479

Balance Sheet

Currency in THB. All numbers in thousands.

	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31
Accounts Payable	1,992	631	690	1,735	1,548	2,607	1,863	1,387	1,963	1,177	1,659	2,117	2,469	869	787
Capital Lease Obligations	34,230	50,013	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital Stock	300,000	300,000	300,000	300,000	-	-	-	-	-	-	-	-	-	-	-
Cash	98,593	100,201	160,282	182,356	244,302	222,498	213,803	376,922	302,464	84,137	53,584	83,930	85,952	44,606	24,238
Common Stock	300,000	300,000	300,000	300,000	300,000	300,000	274,537	272,000	200,000	200,000	200,000	93,000	93,000	93,000	93,000
Common Stock Shares Outstanding	600,000	600,000	600,000	600,000	600,000	-	-	-	-	-	-	-	-	-	-
Intangible Assets	356	503	658	815	972	1,129	1,234	1,343	478	575	523	409	469	633	-
Inventory	59,939	62,328	62,282	66,840	52,688	50,647	50,553	52,273	40,010	40,773	42,296	48,689	48,757	41,472	39,984
Long Term Debt	-	-	-	-	-	-	-	-	-	469	1,353	2,199	153	7	82
Long Term Investments	346,733	331,928	3,609	2,819	1,925	0	503	795	769	-	-	-	-	-	-
Net Invested Capital	594,995	595,464	579,191	614,163	628,311	-	-	-	-	-	-	-	-	-	-
Net Receivables	3,286	5,294	1,443	5,248	4,551	4,967	10,081	12,711	10,591	7,193	11,693	19,342	18,951	14,046	6,674
Net Tangible Assets	594,639	594,961	578,533	613,348	627,340	647,972	566,945	513,701	403,797	-	-	-	-	-	-
Net Working Capital	183,361	191,843	513,326	532,497	535,828	-	-	-	-	-	-	-	-	-	-
Non Current Assets Total	449,420	456,061	85,236	96,305	105,153	115,595	-	-	-	-	-	-	-	-	-
Non Current Liabilities Total	37,787	52,440	19,371	14,639	12,670	11,817	-	-	-	-	-	-	-	-	-
Non Currrent Assets Other	6,070	6,076	5,581	5,973	5,876	5,237	-	-	-	-	-	-	-	-	-
Other Assets	11,123	10,240	9,614	9,064	8,485	7,753	7,361	7,201	3,523	533	786	280	181	537	535
Other Current Assets	302	348	347	623	868	842	558	4,676	4,903	3,408	2,366	1,860	2,139	1,374	1,413
Other Current Liab	13,233	12,950	11,155	16,047	16,880	24,703	22,141	38,806	43,998	38,470	30,097	26,396	41,984	20,899	4,883
Other Liab	22,301	20,848	19,371	14,639	12,670	11,817	11,752	7,369	6,453	5,195	4,637	-	-	-	-
Other Stockholder Equity	1,299	3,258	-	-	-	-	-	-	-	-	-	-	-	-	-
Property Plant Equipment	91,208	113,390	71,355	83,607	93,772	106,712	146,681	105,743	91,509	88,079	71,075	60,129	60,196	59,744	54,932
Retained Earnings	126,751	125,260	112,246	147,219	161,367	182,157	145,204	160,181	121,413	94,480	88,751	92,927	57,619	28,097	8,021
Short Long Term Debt	-	-	-	-	-	-	-	-	469	-	-	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	469	-	-	-	-	-	-
Short Term Investments	68,323	71,835	319,512	313,394	270,520	315,496	195,408	-	-	194,900	225,000	-	-	-	-
Total Assets	680,533	696,778	629,758	665,721	678,780	711,185	628,976	562,605	457,159	423,539	410,217	217,529	226,042	171,749	137,564
Total Current Assets	231,112	240,717	544,522	569,416	573,627	595,591	473,196	446,583	357,968	-	-	-	-	-	-
Total Current Liabilities	47,751	48,874	31,196	36,919	37,799	50,267	49,045	40,192	46,430	40,531	32,614	29,403	52,603	29,940	15,756
Total Liab	85,538	101,314	50,567	51,558	50,468	62,084	60,797	47,561	52,883	46,195	38,604	31,602	52,756	29,947	15,837
Total Stockholder Equity	594,995	595,464	579,191	614,163	628,311	649,101	568,179	515,044	404,276	377,343	371,613	185,927	173,286	141,802	121,726

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-03-31	2009-12-31	2008-12-31	2007-12-31
Accounts Payable	1,929	1,392	1,311	1,992	853	1,432	648	631	1,686	3,062	3,196	690	785	1,818	629	1,735	4,530	1,229	2,289	1,548	1,921	2,118	2,648	1,745	1,948	1,721	1,017	1,863	2,193	1,418	2,096	1,387	3,796	2,499	3,603	1,963	2,451	2,546	2,437	1,177	2,555	1,853	2,183	1,638	1,705	1,722	3,806	2,117	-	3,062	869	788
Capital Lease Obligations	17,674	21,306	24,918	34,230	38,787	43,191	45,415	50,013	1,474	6,243	10,976	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital Stock	300,000	300,000	300,000	300,000	300,000	300,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash	63,721	54,986	118,185	98,593	63,958	49,432	110,911	100,201	81,875	75,672	505,718	160,282	130,984	114,239	204,862	182,356	185,791	172,659	278,141	244,302	195,401	166,192	248,549	222,498	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	274,538	274,538	274,538	274,538	274,538	274,538	272,000	272,000	272,000	272,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	200,000	150,000	93,000	93,000	93,000	-	93,000	93,000	93,000
Common Stock Shares Outstanding	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	600,000	599,598	598,871	599,330	600,254	600,211	599,257	600,214	600,270	599,596	599,146	600,176	600,357	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	356	-	-	-	503	-	-	-	658	698	737	776	815	854	894	933	972	1,011	1,051	1,090	1,129	1,097	1,137	1,185	1,234	1,284	1,335	1,384	1,343	404	429	454	479	488	520	552	575	570	601	632	523	503	431	437	409	-	469	-	-
Inventory	56,851	57,574	58,596	59,939	63,007	65,374	63,498	62,328	66,534	69,260	61,713	62,282	65,264	66,378	63,172	66,840	71,102	56,496	49,585	51,054	55,506	54,066	45,980	48,174	48,368	48,450	48,361	48,118	51,624	53,095	50,375	52,273	55,177	44,715	40,834	40,010	43,287	42,957	41,104	40,773	44,555	42,897	43,684	42,296	44,765	48,398	47,131	48,689	-	53,082	41,472	39,984
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	237	469	697	920	1,139	1,353	1,563	1,769	1,972	2,199	-	153	7	82
Long Term Investments	308,905	327,305	330,416	346,733	341,409	317,221	317,986	331,928	265,521	214,385	3,701	3,609	3,453	3,345	3,197	2,819	2,794	2,450	2,244	1,925	1,398	1,392	1,533	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Invested Capital	574,390	554,440	614,105	594,995	574,306	556,845	606,647	595,464	570,199	561,144	596,377	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Receivables	3,729	10,344	2,603	3,286	3,606	3,980	2,490	5,294	2,244	18,754	1,757	1,443	1,893	3,487	2,800	5,248	5,616	5,939	7,289	4,551	8,979	7,176	6,085	4,967	5,454	6,153	6,307	10,081	11,277	19,681	23,066	13,710	18,756	12,333	8,549	10,591	13,765	10,433	2,914	7,193	6,964	8,683	9,821	11,693	7,834	7,704	19,359	19,342	-	18,952	14,098	6,674
Net Tangible Assets	574,124	554,145	613,780	594,639	573,916	556,418	606,182	594,961	569,658	560,564	595,758	578,533	562,420	547,511	628,730	613,348	588,392	563,263	652,527	627,340	595,786	564,208	672,139	647,972	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Working Capital	209,480	170,584	224,396	183,361	167,325	172,679	221,600	191,843	244,499	283,370	520,963	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Current Assets Total	391,923	414,087	421,617	449,420	448,736	430,134	434,244	456,061	346,144	297,919	95,572	85,236	88,862	92,140	94,432	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Current Liabilities Total	24,622	28,152	31,660	37,787	41,755	45,967	49,197	52,440	20,443	20,144	20,158	19,371	18,983	18,595	14,948	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Currrent Assets Other	4,753	4,756	4,756	6,070	6,297	6,297	6,076	6,076	6,105	6,309	6,309	5,581	6,099	6,098	6,105	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Assets	13,199	11,378	10,380	11,123	11,402	10,857	9,886	10,240	12,141	9,797	10,735	9,614	10,058	10,043	9,283	9,064	9,095	8,934	11,695	11,382	10,777	10,395	10,505	8,883	9,000	9,035	9,080	9,099	9,699	9,623	9,710	10,279	10,595	7,719	6,519	7,682	9,879	8,606	7,546	5,049	3,958	3,980	4,012	4,203	3,692	3,619	4,313	3,579	-	10,423	9,981	10,323
Other Current Assets	355	318	444	302	337	335	357	348	397	379	359	347	382	554	640	623	2,980	2,758	4,291	3,200	4,361	4,895	5,784	4,456	5,866	6,033	6,031	5,786	7,355	4,939	5,444	3,677	4,761	7,592	5,408	4,903	4,358	3,948	4,158	3,408	3,476	3,272	2,272	2,366	3,560	2,965	2,619	1,860	-	1,763	1,215	1,413
Other Current Liab	9,190	13,709	18,416	13,233	7,127	11,806	15,535	12,950	8,986	12,256	16,300	11,155	1,880	1,913	2,110	16,047	9,324	14,082	43,385	36,251	31,684	34,178	48,466	48,522	33,801	40,312	47,519	47,183	31,266	35,159	161,329	38,806	29,543	41,188	123,000	43,999	28,580	32,088	33,241	38,469	24,873	23,719	31,154	30,119	27,453	35,298	34,996	26,395	-	41,390	20,899	4,883
Other Liab	22,497	22,107	21,717	22,301	21,335	20,921	21,262	20,848	20,443	20,049	19,645	19,371	18,983	18,595	14,948	14,639	13,270	13,003	12,937	12,670	12,413	12,331	12,074	11,817	12,550	12,284	12,018	11,752	11,505	11,258	11,011	7,369	7,140	6,911	6,682	6,453	5,645	5,495	5,345	5,195	5,056	4,916	4,775	4,637	4,507	4,377	4,246	-	-	-	-	-
Other Stockholder Equity	-11,365	-4,804	-1,354	1,299	1,294	2,788	5,210	3,258	-4,826	2,479	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property Plant Equipment	69,554	75,109	80,495	91,208	95,535	101,628	105,907	113,390	67,940	73,157	80,517	71,355	74,654	78,014	81,176	83,607	85,274	88,517	90,546	93,772	97,190	100,562	104,019	106,712	134,896	138,570	142,697	146,682	150,415	151,537	146,654	105,743	93,607	90,371	88,043	91,509	84,661	86,015	87,675	88,079	82,112	81,840	82,248	71,075	72,282	71,206	58,982	60,129	-	60,196	60,378	54,932
Retained Earnings	118,810	92,300	148,515	126,751	106,068	87,113	134,492	125,260	108,081	91,721	129,433	112,246	43,506	28,636	109,895	147,219	122,301	97,213	186,516	161,367	129,853	98,314	206,284	182,157	136,570	103,636	170,073	145,204	108,227	86,896	66,755	160,181	142,812	108,496	69,894	121,413	96,565	75,106	108,051	94,480	76,547	62,058	101,162	88,751	74,912	61,450	98,928	92,927	-	63,906	28,097	8,021
Short Term Investments	123,809	87,060	91,558	68,323	73,971	97,048	90,513	71,835	125,429	157,480	534	319,512	316,514	315,972	313,399	313,394	271,090	271,002	270,525	270,520	270,601	270,601	315,496	315,496	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	641,478	626,889	694,638	680,533	654,413	647,225	702,894	696,778	623,626	620,583	666,709	629,758	608,053	597,050	684,907	665,721	636,300	611,350	712,071	678,780	642,814	613,887	736,417	711,185	607,845	580,929	653,602	628,976	576,166	557,706	596,053	562,605	538,153	513,956	486,042	457,159	417,484	399,019	433,077	423,539	393,458	377,178	424,119	410,217	261,013	198,503	237,851	217,529	-	230,367	171,749	137,564
Total Current Assets	249,555	212,802	273,021	231,112	205,677	217,091	268,650	240,717	277,482	322,664	571,136	544,522	519,191	504,910	590,475	569,416	538,283	510,555	609,830	573,627	534,848	502,930	621,894	595,591	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	40,075	42,218	48,625	47,751	38,352	44,412	47,050	48,874	32,983	39,294	50,173	31,196	25,952	30,208	40,453	36,919	33,784	34,190	45,674	37,799	33,604	36,297	51,115	50,267	35,749	42,034	48,536	49,045	33,459	36,577	163,424	40,192	33,339	43,687	126,603	46,430	32,411	35,554	36,580	40,531	28,296	26,421	34,181	32,614	30,030	37,907	39,705	29,403	-	52,603	29,940	15,756
Total Liab	64,697	70,370	80,285	85,538	80,107	90,379	96,247	101,314	53,426	59,438	70,331	50,567	44,935	48,802	55,401	51,558	47,054	47,193	58,611	50,468	46,017	48,628	63,189	62,084	48,299	54,318	60,554	60,797	44,964	47,835	174,435	47,561	40,479	50,598	133,285	52,883	38,055	41,049	42,162	46,195	34,048	32,257	40,094	38,604	36,100	44,053	45,923	31,602	-	52,756	29,947	15,837
Total Stockholder Equity	574,390	554,440	614,105	594,995	574,306	556,845	606,647	595,464	570,199	561,144	596,377	579,191	563,118	548,248	629,506	614,163	589,246	564,157	653,460	628,311	596,797	565,259	673,229	649,101	559,546	526,612	593,048	568,179	531,202	509,871	421,617	515,044	497,675	463,359	352,757	404,276	379,428	357,969	390,914	377,343	359,409	344,921	384,025	371,613	224,912	154,450	191,928	185,927	177,611	177,611	141,802	121,726

Cash Flow

Currency in THB. All numbers in thousands.

	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31
Begin Period Cash Flow	100,201	160,282	182,356	244,302	222,498	-	-	-	-	-	-	-	-	-	-
Capital Expenditures	1,174	4,175	1,207	3,430	1,777	1,336	53,659	25,119	15,909	20,725	17,750	3,917	0	0	190
Change In Cash	-1,608	-60,081	-22,074	-61,946	21,804	8,695	-163,119	74,458	218,327	-	-	-	-	-	-
Change In Working Capital	-219	-9,802	6,756	-16,011	-8,859	-	-	-	-	-	-	-	-	-	-
Change To Account Receivables	2,866	-2,784	3,788	-559	867	2,475	6,325	-1,852	-5,475	4,741	-	9,264	-	-	-
Change To Inventory	1,075	106	3,703	-14,301	-3,194	-155	4,665	-12,034	1,497	1,761	5,031	-	-	-	2,971
Change To Liabilities	-134	2,083	-1,015	-677	-4,777	-2,756	4,232	-3,521	5,711	-	-	-	-	-	-
Change To Netincome	-11,041	-13,460	-6,553	-5,275	-11,566	-27,276	6,508	-1,941	5,540	-	-	-	-	-	-
Change To Operating Activities	-4,026	-414	280	-473	-1,755	-464	1,093	-3,926	-291	-	-	-	-	-	-
Depreciation	26,811	31,088	13,457	13,622	14,299	17,021	15,411	8,647	8,302	-	-	-	-	-	-
Dividends Paid	-71,952	-56,961	-92,876	-108,000	129,000	95,265	115,600	40,000	54,000	50,000	50,220	31,620	-	-	-
End Period Cash Flow	98,593	100,201	160,282	182,356	244,302	222,498	-	-	-	-	-	-	-	-	-
Free Cash Flow	83,222	82,573	70,514	83,809	100,465	-	-	-	-	-	-	-	-	-	-
Investments	-6,130	-70,862	-4,770	-42,874	43,577	-64,725	-195,408	-125	194,900	-	-	-	-	-	-
Net Borrowings	-18,137	-18,735	-18,735	-18,735	-18,735	-	-	-469	-884	-	-	-	-	-	-
Net Income	68,699	69,975	57,904	94,746	108,210	131,418	100,623	118,768	78,845	55,730	50,160	44,261	54,411	20,075	-
Other Cashflows From Financing Activities	-864	-477	-477	-477	-477	-	-	-	-	1	-	-	-	-	-
Other Cashflows From Investing Activities	11,831	4,375	5,059	5,021	6,252	9,446	-4,566	1,972	-8	-	-	-	-	-	-
Other Non Cash Items	-7,232	1,717	-4,639	-5,154	-5,426	-	-	-	-	-	-	-	-	-	-
Sale Purchase Of Stock	-	-	-	-	-	43,969	68,113	32,000	32,000	-	-	-	-	-	-
Total Cash From Financing Activities	-90,954	-76,173	-92,876	-108,000	-129,000	-51,295	-47,487	-8,469	-54,884	-	138,765	-	-	-	7,327
Total Cash From Operating Activities	84,397	86,749	71,720	87,238	102,242	120,264	139,054	104,245	94,252	73,315	62,958	41,128	-	-	6,762
Total Cashflows From Investing Activities	4,949	-70,657	-918	-41,184	48,562	-60,274	-254,685	-21,318	178,959	8,095	-	-	-	-	-

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2008-12-31	2007-12-31
Begin Period Cash Flow	54,986	118,185	98,593	63,958	49,432	110,911	100,201	81,875	75,672	505,718	160,282	130,984	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital Expenditures	20	205	33	671	248	127	128	592	1,864	354	1,366	31	38	537	600	1,383	179	1,699	168	1,777	1,947	1,254	940	1,261	1,043	444	314	53,659	53,233	49,111	37,504	25,119	14,925	7,604	2,520	15,909	8,030	6,589	4,086	20,726	16,262	14,105	12,678	17,750	15,757	14,101	1,054	3,917	3,494	1,687	420	7,663	12,650	190
Change In Cash	8,734	-63,199	19,592	34,635	14,526	-61,479	10,709	18,326	6,203	-430,046	345,436	29,298	16,746	-90,623	22,506	-3,435	13,132	-105,482	33,839	48,901	29,209	-82,358	26,052	83,645	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change In Working Capital	2,676	-1,738	-2,096	6,718	174	-4,070	-3,041	-5,261	5,048	-12,370	2,781	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change To Account Receivables	491	-335	-1,019	1,536	-183	-736	2,249	-512	694	-1,008	-1,958	1,432	2,634	-732	454	1,046	744	527	-2,876	867	-1,302	-216	-2,477	1,727	-	-	-	6,325	6,233	-	-	-	-	-	2,742	-	-	-	3,291	4,741	4,722	3,126	2,032	-	1,461	1,591	106	9,264	-	-	690	-	-	-
Change To Inventory	586	28	1,195	2,474	2,470	-1,961	-1,909	4,445	2,182	-8,091	1,570	3,659	1,058	-3,266	2,252	5,635	-14,627	-7,006	1,697	4,300	-1,682	-8,043	2,231	114	-	-	-	4,665	991	-	1,980	-	-	-	-	1,497	-	-	24	1,761	-	-	-	5,031	2,758	-	1,308	-	-	-	-	-	-	2,971
Change To Liabilities	1,416	-1,532	-509	4,932	-2,059	-313	-2,694	-9,509	1,467	-2,438	3,770	676	-510	-1,223	42	-3,627	4,415	-3,719	2,254	-733	602	-758	-3,888	3,571	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change To Netincome	-7,462	-8,419	3,501	3,424	-7,368	-8,073	975	7,142	-7,348	-8,564	4,102	3,217	-4,859	-7,288	2,377	4,458	-5,922	-8,704	4,893	-1,471	-3,456	-13,220	6,581	-16,626	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change To Operating Activities	182	101	-1,762	-2,224	-54	-1,061	-688	315	704	-833	-601	1,034	139	-105	-788	703	-89	-505	-581	366	-272	-372	-1,477	396	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation	5,576	5,559	6,397	6,343	6,441	6,617	7,411	7,816	7,681	7,713	7,878	3,367	3,439	3,422	3,385	3,423	3,422	3,384	3,393	3,515	3,586	3,600	3,599	4,036	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-73,990	-73,990	-73,990	-73,990	71,952	71,952	71,952	71,952	56,961	56,961	0	0	92,876	92,876	92,876	92,876	108,000	108,000	129,000	129,000	129,000	129,000	95,265	95,265	95,265	-	115,600	115,600	115,600	-	40,000	40,000	40,000	-	54,000	54,000	54,000	-	50,000	50,000	50,000	-	50,220	50,220	50,220	-	31,620	31,620	31,620	-	20,460	-	-
End Period Cash Flow	63,721	54,986	118,185	98,593	63,958	49,432	110,911	100,201	81,875	75,672	505,718	160,282	130,984	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow	21,724	12,409	23,117	37,382	17,991	13,363	14,486	26,324	19,915	5,713	30,622	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments	-12,546	-2,834	-2,010	-1,267	-2,286	-755	-1,822	-2,716	-10,287	-57,854	-5	-160	-25	-173	-560	-42,304	-88	-477	-5	81	352	44,895	-1,750	-50,088	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Borrowings	-3,632	-3,612	-4,439	-4,557	-4,404	-4,579	-4,598	-4,535	-4,768	-4,733	-4,699	-4,699	-4,699	-4,699	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	20,924	17,181	15,317	21,533	18,955	18,979	9,231	17,180	16,359	19,249	17,187	16,073	14,870	11,618	15,343	25,811	25,089	18,697	25,149	31,514	31,539	21,030	24,127	44,787	32,934	28,828	24,869	36,977	21,331	20,141	22,173	17,369	34,316	38,602	28,481	25,375	21,459	21,055	10,956	17,934	14,489	10,896	12,411	13,839	13,462	12,742	10,117	11,316	9,471	10,575	12,899	-	-	-
Other Cashflows From Financing Activities	-124	1,856	55	-186	-209	-224	-245	-268	-34	-70	-104	-104	-104	-104	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Cashflows From Investing Activities	3,313	2,973	2,747	3,205	3,433	2,662	2,532	-480	1,377	-316,144	319,622	2,064	13	2,937	45	2,666	329	1,982	44	6,253	-1	-1	-1	4,995	5,000	5,000	5,000	-	-	-	-	1,972	1,999	2,000	2,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non Cash Items	-2,081	-2,057	-1,931	-2,495	-1,786	-1,540	-1,411	2,727	-708	-390	87	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sale Purchase Of Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43,969	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Cash From Financing Activities	-3,756	-75,746	-4,384	-4,744	-4,612	-76,755	-4,843	-4,803	-4,803	-61,764	-4,803	0	0	-92,876	-92,876	-92,876	-92,876	-108,000	-108,000	-108,000	-108,000	-129,000	-129,000	43,969	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	138,765	6,127	-	-	-	-	-	-	-	-	7,327
Total Cash From Operating Activities	21,744	12,614	23,150	38,053	18,239	13,490	14,614	26,916	21,779	6,067	31,987	29,458	16,771	2,427	23,066	37,488	13,071	2,712	33,967	102,242	59,850	30,797	28,736	124,715	86,358	54,185	27,229	139,054	75,706	44,564	27,445	104,245	72,362	61,012	33,392	94,252	44,510	29,054	14,951	73,315	40,856	22,604	16,543	62,958	44,695	35,454	22,836	41,128	11,454	9,034	11,328	69,240	32,822	6,763
Total Cashflows From Investing Activities	-9,254	-66	826	1,326	899	1,786	938	-3,787	-10,773	-374,349	318,252	-160	-25	-173	-560	-40,923	62	-194	-128	48,562	42,054	41,897	-2,684	1,320	-	129,457	-	-	-	-	-	-	-	-	1,303	178,959	186,860	175,403	145,906	8,095	161,601	28,759	212,185	-	-	-	-	-	-	-	-	-	-	-

Income Statement

Currency in THB. All numbers in thousands.

	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31
Cost Of Revenue	46,264	52,874	51,805	64,889	67,486	59,597	64,954	61,016	50,029	39,004	46,821	41,840	58,769	27,597	6,053
Ebit	73,820	75,535	65,580	110,144	122,768	154,480	119,144	140,661	96,883	-	-	-	-	-	-
Ebitda	113,312	118,787	78,503	123,923	137,225	-	-	-	-	-	-	-	-	-	-
Gross Profit	177,088	194,852	195,849	304,945	348,256	361,782	344,297	356,046	290,088	-	-	-	-	-	-
Income Before Tax	85,490	87,067	72,356	117,656	131,639	164,259	125,429	147,801	103,854	71,837	71,116	64,558	79,266	27,681	-
Income Tax Expense	16,791	17,091	14,452	22,911	23,429	32,841	24,807	29,033	25,009	16,107	20,956	20,296	24,854	7,605	1,012
Interest Expense	864	477	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	7,622	12,019	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	68,699	69,975	57,904	94,746	108,210	131,418	100,623	118,768	78,845	55,730	50,160	44,261	54,411	20,075	-
Net Income Applicable To Common Shares	68,699	69,975	57,904	94,746	108,210	131,418	100,623	118,768	78,845	55,730	50,160	44,261	54,411	20,075	-
Net Income From Continuing Ops	68,699	69,975	57,904	94,746	108,210	131,418	100,623	118,768	78,845	-	-	-	-	-	-
Net Interest Income	6,758	11,543	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	73,820	75,535	64,889	110,144	122,768	137,459	119,144	140,661	96,883	63,652	66,990	59,085	79,289	27,872	-
Other Operating Expenses	-3,025	-5,409	-691	-691	691	-	-	-	-	-	-	-	-	-	-
Reconciled Depreciation	26,958	31,244	13,613	13,779	14,457	-	-	-	-	-	-	-	-	-	-
Research Development	-	-	-	-	16,579	-	-	-	-	-	-	-	-	-	-
Selling General Administrative	106,293	124,727	130,960	194,800	225,488	230,354	225,153	215,385	193,205	175,699	170,501	147,782	154,490	88,256	46,234
Tax Provision	16,791	17,091	14,452	22,911	23,429	32,841	-	-	-	-	-	-	-	-	-
Total Operating Expenses	149,532	172,192	182,765	259,690	292,974	283,920	290,107	285,153	251,658	-	-	-	-	-	-
Total Other Income Expense Net	4,912	-11	7,467	7,512	8,871	26,800	6,285	7,140	6,971	-	-	-	-	-	-
Total Revenue	223,352	247,726	247,654	369,834	415,742	421,379	409,251	425,814	348,541	285,959	290,747	255,693	290,659	140,394	55,595

	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31
Cost Of Revenue	11,927	10,627	10,984	12,868	11,227	12,076	10,092	14,863	13,047	11,648	13,316	12,671	12,672	13,783	12,680	18,490	16,389	13,676	12,903	14,267	15,224	12,806	10,733	10,997	11,347	10,500	9,732	13,823	10,097	11,364	14,062	14,855	16,744	15,437	13,980	15,437	11,762	15,865	6,965	13,377	9,440	8,167	8,020	11,384	12,539	8,707	12,730	12,149	12,225	9,770	10,372
Ebit	23,038	17,654	17,297	24,968	19,754	19,380	9,718	17,575	16,612	18,029	29,291	21,558	20,339	16,062	22,081	29,295	29,557	21,456	29,837	31,460	37,595	24,820	28,894	26,841	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Ebitda	31,457	27,000	26,017	33,558	29,916	30,542	19,296	29,377	28,181	31,937	29,291	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	50,854	47,218	44,566	49,237	43,763	46,409	37,679	51,583	49,172	45,928	48,170	31,314	50,578	50,791	63,166	82,441	76,808	67,059	82,069	94,344	95,552	89,376	83,442	93,606	100,622	95,059	89,516	112,894	83,139	81,507	82,365	83,051	93,914	101,461	86,372	91,695	76,994	73,136	56,687	74,849	64,368	52,565	55,173	61,171	65,276	62,400	56,830	55,039	52,380	47,564	56,194
Income Before Tax	25,727	21,267	19,394	26,994	23,229	23,663	11,603	21,254	20,427	24,116	21,270	20,111	18,625	14,546	19,074	31,634	31,291	23,351	31,380	35,630	39,334	26,399	30,277	55,797	40,932	36,366	31,164	46,313	26,649	24,580	27,887	21,275	42,593	48,290	35,643	36,061	27,093	26,896	13,804	22,435	19,201	14,299	15,902	17,931	19,484	18,996	14,705	16,073	14,123	14,933	19,429
Income Tax Expense	4,490	4,254	4,080	5,461	4,274	4,684	2,372	4,074	4,068	4,866	4,083	4,038	3,755	2,928	3,731	5,823	6,203	4,654	6,231	4,116	7,795	5,369	6,150	11,010	7,997	7,539	6,295	9,337	5,318	4,439	5,714	3,906	8,277	9,688	7,162	10,686	5,634	5,840	2,848	4,502	4,713	3,403	3,491	4,092	6,022	6,254	4,588	4,757	4,651	4,358	6,530
Interest Expense	124	144	195	186	209	224	245	268	34	70	104	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	-	-	14	14	17	21	35	33	47	40	45	50	55	57	60	64	67	3	4
Interest Income	2,205	2,202	2,126	2,207	1,994	1,764	1,656	-	-	459	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-313	-	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	20,924	17,013	15,317	21,533	18,955	18,979	9,231	17,180	16,359	19,249	17,187	16,073	14,870	11,618	15,343	25,811	25,089	18,697	25,149	31,514	31,539	21,030	24,127	44,787	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Applicable To Common Shares	20,924	17,181	15,317	21,533	18,955	18,979	9,231	17,180	16,359	19,249	17,187	16,073	14,870	11,618	15,343	25,811	25,089	18,697	25,149	31,514	31,539	21,030	24,127	44,787	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	21,237	17,013	15,314	21,533	18,955	18,979	9,231	17,180	16,359	19,249	17,187	16,073	14,870	11,618	15,343	25,811	25,089	18,697	25,149	31,514	31,539	21,030	24,127	44,787	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Interest Income	2,081	2,057	1,931	2,021	1,786	1,540	1,411	11,751	-34	390	-104	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	23,038	17,654	17,297	24,968	19,754	19,380	9,718	16,797	19,591	18,028	20,494	18,191	16,901	12,640	18,696	29,295	29,557	21,456	29,837	31,460	37,595	24,820	28,894	26,841	39,910	34,858	29,818	44,830	25,015	22,923	26,377	19,389	40,860	46,502	33,910	34,027	25,527	25,209	12,119	19,879	17,575	12,463	13,735	14,813	19,253	18,518	14,406	12,269	13,109	14,630	19,077
Other Operating Expenses	-83	-26	-494	-2,335	15	275	400	3,101	517	1	788	788	788	788	1,538	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reconciled Depreciation	5,606	5,589	6,428	6,377	6,478	6,654	7,449	7,855	7,719	7,751	7,917	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling General Administrative	27,900	29,589	27,763	26,604	24,024	27,304	28,362	37,109	32,043	27,900	27,676	13,123	33,678	38,152	46,008	53,146	47,251	45,603	48,800	59,330	54,332	60,917	50,909	62,687	56,398	55,896	55,374	63,685	53,776	54,544	53,148	61,428	50,837	52,827	50,292	55,542	49,344	45,819	42,500	52,982	44,878	38,237	39,602	44,642	44,373	42,330	40,907	40,822	37,384	31,117	35,783
Tax Provision	4,490	4,254	4,080	5,461	4,274	4,684	2,372	4,074	4,068	4,866	4,083	4,038	3,755	2,928	3,731	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	39,744	40,190	38,252	37,137	35,237	39,104	38,054	49,650	42,628	39,547	40,992	25,794	46,349	51,934	57,150	71,636	63,640	59,278	65,135	77,151	73,180	77,362	65,281	77,761	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Other Income Expense Net	608	1,555	166	6	1,690	2,743	474	-7,294	871	5,698	880	1,921	1,725	1,906	378	2,339	1,734	1,895	1,544	4,170	1,739	1,579	1,383	28,955	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Revenue	62,781	57,844	55,550	62,105	54,990	58,484	47,772	66,446	62,219	57,576	61,486	43,985	63,250	64,574	75,845	100,931	93,197	80,734	94,972	108,611	110,775	102,182	94,175	104,603	111,969	105,559	99,248	126,717	93,236	92,871	96,427	97,906	110,658	116,898	100,352	107,132	88,756	89,001	63,652	88,226	73,808	60,732	63,194	72,555	77,815	71,107	69,560	67,188	64,605	57,334	66,566

Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue	223,352
Cost of Revenue	-46,264
Gross Profit	177,088	177,088

Operating Income (+$)
Gross Profit	177,088
Operating Expense	-149,532
Operating Income	73,820	27,556

Operating Expense (+$)
Research Development	-
Selling General Administrative	106,293
Selling And Marketing Expenses	-
Operating Expense	149,532	106,293

Net Interest Income (+$)
Interest Income	7,622
Interest Expense	-864
Net Interest Income	6,758	6,758

Pretax Income (+$)
Operating Income	73,820
Net Interest Income	6,758
Other Non-Operating Income Expenses	-
Income Before Tax (EBT)	85,490	68,908 EBIT - interestExpense = 72,956 85,490 69,563
Interest Expense	864
Earnings Before Interest and Taxes (ebit)	73,820	86,354
Earnings Before Interest and Taxes (ebitda)	113,312

After tax Income (+$)
Income Before Tax	85,490
Tax Provision	-16,791
Net Income From Continuing Ops	68,699	68,699
Net Income	68,699
Net Income Applicable To Common Shares	68,699

Non-recurring Events
Discontinued Operations	-
Extraordinary Items	-
Effect of Accounting Charges	-
Other Items	-
Non Recurring	-
Other Operating Expenses	-3,025
Total Other Income/Expenses Net	4,912	-6,758